Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person18
Altimmune, Inc.
Company
Evommune, Inc.
Company
ALTABA INC.
Company
IMMUNIC, INC.
Company
Immunome Inc.
Company
AlTi Global, Inc.
Company
Inmune Bio, Inc.
Company
AIM ImmunoTech Inc.
Company
Immunovant, Inc.
Company
ALICO, INC.
Company
Alset Inc.
Company
ImmunityBio, Inc.
Company
ALUMIS INC.
Company
ALLIENT INC
Company
Alector, Inc.
Company
AleAnna, Inc.
Company
Adagene Inc.
Company
Alopexx, Inc.
Company
Primary record12
Altimmune, Inc. filed 4
SEC form 4 filed by Altimmune, Inc. (CIK 1326190) on 2026-11-04.
Altimmune, Inc. filed 4
SEC form 4 filed by Altimmune, Inc. (CIK 1326190) on 2026-11-04.
Altimmune, Inc. filed 8-K
Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. On October 27, 2026, Altimmune, Inc. (the “Company”), has drawn $10.0 million in an aggregate
Altimmune, Inc. filed 8-K
Item 5.02 Election of Directors; Appointment of Certain Officers; Departure of Directors or Certain Officers; Compensatory Arrangements of Certain Officers On October 23, 2026, the Board of Directors, upon the recommenda
Altimmune, Inc. filed 4
SEC form 4 filed by Altimmune, Inc. (CIK 1326190) on 2026-10-05.
Altimmune, Inc. filed 4
SEC form 4 filed by Altimmune, Inc. (CIK 1326190) on 2026-10-05.
Altimmune, Inc. filed 4
SEC form 4 filed by Altimmune, Inc. (CIK 1326190) on 2026-10-02.
Altimmune, Inc. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 24, 2026, the Board of Directors (the Board ) of A
Altimmune, Inc. filed 4
SEC form 4 filed by Altimmune, Inc. (CIK 1326190) on 2026-09-17.
NewAmsterdam Pharma Co N.V. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 10, 2026, NewAmsterdam Pharma Company N.V. (the “Comp
Altimmune, Inc. filed 4
SEC form 4 filed by Altimmune, Inc. (CIK 1326190) on 2026-08-13.
Altimmune, Inc. filed 8-K
Item 2.02 Results of Operations and Financial Condition On August 12, 2026, Altimmune, Inc. (the Company ) issued a press release announcing the Company s financial results for its second quarter ended June 30, 2026. A c